GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
X

Xiamen Comfort Science & Technology Group Co 002614.SZ · CNY

Consumer Discretionary · Shenzhen · 🇨🇳 China

Compare

6.93

+1.32%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥5.09bn

FY2016FY2025

Net income

CN¥12.3m

FY2016FY2025

Free cash flow

−CN¥209.8m

FY2016FY2025

Shareholders' equity

CN¥4.39bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥5.09bnCN¥4.83bnCN¥5.03bnCN¥6.02bnCN¥7.93bnCN¥7.06bnCN¥5.28bnCN¥5.45bnCN¥4.29bnCN¥3.45bn
Gross profitCN¥1.73bnCN¥1.74bnCN¥1.84bnCN¥1.94bnCN¥2.30bnCN¥2.41bnCN¥1.96bnCN¥1.97bnCN¥1.59bnCN¥1.23bn
Research and developmentCN¥224.0mCN¥231.5mCN¥218.5mCN¥246.7mCN¥289.4mCN¥268.8mCN¥226.9mCN¥183.4mCN¥134.6mCN¥134.8m
Operating incomeCN¥42.5mCN¥105.2mCN¥193.3mCN¥178.4mCN¥534.5mCN¥494.3mCN¥356.7mCN¥533.6mCN¥399.3mCN¥310.5m
Net incomeCN¥12.3mCN¥64.2mCN¥103.2mCN¥102.0mCN¥458.4mCN¥439.3mCN¥289.0mCN¥439.1mCN¥345.2mCN¥251.0m
Diluted earnings per share0.030.100.200.150.690.670.520.780.610.43

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥7.48bnCN¥7.58bnCN¥8.02bnCN¥8.71bnCN¥9.26bnCN¥8.96bnCN¥6.14bnCN¥5.94bnCN¥4.83bnCN¥4.40bn
Cash and short-term investments—CN¥1.23bnCN¥2.84bnCN¥3.40bnCN¥2.95bnCN¥3.50bnCN¥860.8mCN¥1.36bnCN¥770.8mCN¥539.1m
Total liabilitiesCN¥3.05bnCN¥3.11bnCN¥3.42bnCN¥3.89bnCN¥4.18bnCN¥4.23bnCN¥2.75bnCN¥2.66bnCN¥1.92bnCN¥1.84bn
DebtCN¥64.4mCN¥1.24bnCN¥1.12bnCN¥1.22bnCN¥1.23bnCN¥1.13bnCN¥613.6mCN¥638.1mCN¥570.2mCN¥722.6m
Shareholders' equityCN¥4.39bnCN¥4.43bnCN¥4.58bnCN¥4.66bnCN¥4.83bnCN¥4.49bnCN¥3.32bnCN¥3.23bnCN¥2.87bnCN¥2.52bn
Shares outstanding491m657m526m684m662m659m551m560m568m583m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥40.5mCN¥130.2mCN¥895.1mCN¥742.1m−CN¥17.5mCN¥714.6mCN¥276.3mCN¥475.6mCN¥302.7mCN¥119.2m
Capital spending−CN¥250.3m−CN¥220.6m−CN¥246.3m−CN¥319.4m−CN¥392.8m−CN¥416.2m−CN¥1.03bn−CN¥431.0m−CN¥113.9m−CN¥82.5m
Free cash flow−CN¥209.8m−CN¥90.4mCN¥648.9mCN¥422.7m−CN¥410.3mCN¥298.4m−CN¥754.2mCN¥44.6mCN¥188.8mCN¥36.6m
Dividends paid−CN¥80.6m−CN¥210.3m−CN¥216.3m−CN¥186.8m−CN¥184.3m−CN¥110.6m−CN¥56.0m−CN¥78.3m−CN¥74.5m−CN¥65.6m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥1.43bnCN¥1.28bnCN¥1.36bnCN¥1.40bnCN¥1.18bnCN¥1.15bnCN¥1.40bnCN¥1.23bn
Gross profitCN¥455.7mCN¥390.6mCN¥442.2mCN¥470.4mCN¥416.1mCN¥397.2mCN¥492.1mCN¥402.1m
Operating incomeCN¥39.9m−CN¥27.6mCN¥2.8mCN¥38.1mCN¥35.9mCN¥1.4mCN¥28.9mCN¥31.6m
Net income−CN¥7.8m−CN¥66.1m−CN¥43.0mCN¥28.2mCN¥25.0mCN¥2.0mCN¥13.2mCN¥27.3m
Diluted earnings per share-0.02-0.13-0.090.060.050.000.020.04
Cash from operations————CN¥72.0m−CN¥85.0m—CN¥207.0m
Capital spending−CN¥24.0m−CN¥34.0m−CN¥37.0m−CN¥47.0m−CN¥57.0m−CN¥107.0m−CN¥54.0m−CN¥83.0m
Free cash flow————CN¥15.0m−CN¥192.0m—CN¥124.0m
Total assetsCN¥7.09bnCN¥7.01bnCN¥7.48bnCN¥7.61bnCN¥7.41bnCN¥7.39bnCN¥7.58bnCN¥7.27bn
Cash and short-term investments———CN¥1.19bnCN¥1.21bnCN¥1.08bnCN¥1.23bnCN¥1.33bn
DebtCN¥39.3mCN¥63.9mCN¥64.4mCN¥1.55bnCN¥545.4mCN¥591.5mCN¥1.13bnCN¥949.2m
Shareholders' equityCN¥4.21bnCN¥4.32bnCN¥4.39bnCN¥4.40bnCN¥4.42bnCN¥4.45bnCN¥4.43bnCN¥4.44bn

Financial ratios

Data as of 18 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin33.9%36.0%36.5%32.1%29.0%34.1%
Operating margin1.8%3.0%4.2%3.8%7.3%7.5%
Net margin0.2%1.3%2.1%1.7%5.8%6.2%
Return on equity0.3%1.4%2.3%2.2%9.5%9.8%
Return on assets0.2%0.8%1.3%1.2%4.9%4.9%
Free cash flow yield6.8%6.1%24.7%17.7%6.5%19.6%
Revenue growth5.2%-3.9%-16.5%-24.0%12.3%33.8%
Earnings growth-80.9%-37.8%1.2%-77.7%4.3%52.0%
Current ratio1.55x1.67x1.79x1.99x1.79x1.89x
Debt to equity0.01x0.26x0.30x0.22x0.17x0.25x
Equity ratio58.7%58.5%57.1%53.5%52.1%50.1%
Interest coverage1.86x2.77x3.66x3.30x9.52x10.12x
R&D as a share of sales4.4%4.8%4.3%4.1%3.7%3.8%
Buybacks as a share of market value25.3%-24.8%23.0%-3.3%-0.3%-19.6%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-5.5%-6.3%6.0%
Operating income-38.0%-38.8%-14.2%
Net income-50.6%-51.1%-23.6%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin34.9%34.5%33.2%34.2%
Operating margin1.5%2.5%4.3%5.8%
Net margin0.8%1.3%3.3%4.7%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings292.467.738.262.518.620.220.220.331.831.0
Price to sales0.70.90.81.11.11.31.11.62.62.3

Dividends and splits

Per share, in the currency the company pays

Paid for 14 years. Last went ex-dividend on 29 May 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year0.100.100.300.300.300.300.200.10
  • 3-for-2 split · 28 May 2015
  • 3-for-2 split · 23 May 2014
  • 2-for-1 split · 29 Mar 2012

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.